These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 3510720

  • 1. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
    Bregni M, De Fabritiis P, Raso V, Greenberger J, Lipton J, Nadler L, Rothstein L, Ritz J, Bast RC.
    Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
    [Abstract] [Full Text] [Related]

  • 2. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement.
    Bast RC, De Fabritiis P, Lipton J, Gelber R, Maver C, Nadler L, Sallan S, Ritz J.
    Cancer Res; 1985 Feb; 45(2):499-503. PubMed ID: 3967224
    [Abstract] [Full Text] [Related]

  • 3. Selective killing of human T-lymphotropic virus-I infected leukemic T-cells by monoclonal anti-interleukin 2 receptor antibody-ricin A chain conjugates: potentiation by ammonium chloride and monensin.
    Krönke M, Schlick E, Waldmann TA, Vitetta ES, Greene WC.
    Cancer Res; 1986 Jul; 46(7):3295-8. PubMed ID: 3011246
    [Abstract] [Full Text] [Related]

  • 4. Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow.
    Uckun FM, Ramakrishnan S, Houston LL.
    J Immunol; 1985 Mar; 134(3):2010-6. PubMed ID: 3855433
    [Abstract] [Full Text] [Related]

  • 5. Elimination of clonogenic T-leukemic cells from human bone marrow using anti-Mr 65,000 protein immunotoxins.
    Stong RC, Youle RJ, Vallera DA.
    Cancer Res; 1984 Jul; 44(7):3000-6. PubMed ID: 6372999
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Selective removal of clonogenic neoplastic B cells from human bone marrow using anti-HLA-DQ antibodies and complement.
    Falkenburg JH, Fibbe WE, Veenhof WF, Koning F, van Eeden G, Voogt PJ, Jansen J.
    Exp Hematol; 1986 Feb; 14(2):101-7. PubMed ID: 2417877
    [Abstract] [Full Text] [Related]

  • 8. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
    Raso V, Ritz J, Basala M, Schlossman SF.
    Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
    Ghetie MA, May RD, Till M, Uhr JW, Ghetie V, Knowles PP, Relf M, Brown A, Wallace PM, Janossy G.
    Cancer Res; 1988 May 01; 48(9):2610-7. PubMed ID: 2451562
    [Abstract] [Full Text] [Related]

  • 10. Evidence for absence of toxicity of T101 immunotoxin on human hematopoietic progenitor cells prior to bone marrow transplantation.
    Douay L, Gorin NC, Lopez M, Casellas P, Liance MC, Jansen FK, Voisin GA, Baillou C, Laporte JP, Najman A.
    Cancer Res; 1985 Jan 01; 45(1):438-41. PubMed ID: 3880666
    [Abstract] [Full Text] [Related]

  • 11. Efficient transplantation of human non-T-leukemia cells into nude mice and induction of complete regression of the transplanted distinct tumors by ricin A-chain conjugates of monoclonal antibodies SN5 and SN6.
    Hara H, Luo Y, Haruta Y, Seon BK.
    Cancer Res; 1988 Aug 15; 48(16):4673-80. PubMed ID: 2969282
    [Abstract] [Full Text] [Related]

  • 12. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.
    Bast RC, Ritz J, Lipton JM, Feeney M, Sallan SE, Nathan DG, Schlossman SF.
    Cancer Res; 1983 Mar 15; 43(3):1389-94. PubMed ID: 6337707
    [Abstract] [Full Text] [Related]

  • 13. Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies.
    Kvalheim G, Fodstad O, Pihl A, Nustad K, Pharo A, Ugelstad J, Funderud S.
    Cancer Res; 1987 Feb 01; 47(3):846-51. PubMed ID: 3492268
    [Abstract] [Full Text] [Related]

  • 14. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
    Cazzola M, Bergamaschi G, Dezza L, D'Uva R, Ponchio L, Rosti V, Ascari E.
    Cancer Res; 1991 Jan 15; 51(2):536-41. PubMed ID: 1985771
    [Abstract] [Full Text] [Related]

  • 15. Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis.
    Slaper-Cortenbach IC, Admiraal LG, van Leeuwen EF, Kerr JM, von dem Borne AE, Tetteroo PA.
    Exp Hematol; 1990 Jan 15; 18(1):49-54. PubMed ID: 2298269
    [Abstract] [Full Text] [Related]

  • 16. Combined chemoseparation and immunoseparation of clonogenic T lymphoma cells from human bone marrow using 2'-deoxycoformycin, deoxyadenosine, 3A1 monoclonal antibody, and complement.
    Haleem A, Kurtzberg J, Olsen GA, Rhinehardt-Clark A, Leslie DS, Ray L, Smith CA, Peters WP, Haynes BF, Bast RC.
    Cancer Res; 1987 Sep 01; 47(17):4608-12. PubMed ID: 3113721
    [Abstract] [Full Text] [Related]

  • 17. Elimination of malignant clonogenic breast cancer cells from human bone marrow.
    Anderson IC, Shpall EJ, Leslie DS, Nustad K, Ugelstad J, Peters WP, Bast RC.
    Cancer Res; 1989 Aug 15; 49(16):4659-64. PubMed ID: 2663144
    [Abstract] [Full Text] [Related]

  • 18. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S, Houston LL.
    Cancer Res; 1984 Apr 15; 44(4):1398-404. PubMed ID: 6142765
    [Abstract] [Full Text] [Related]

  • 19. Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement.
    De Fabritiis P, Bregni M, Lipton J, Greenberger J, Nadler L, Rothstein L, Korbling M, Ritz J, Bast RC.
    Blood; 1985 May 15; 65(5):1064-70. PubMed ID: 3995166
    [Abstract] [Full Text] [Related]

  • 20. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia.
    Guyotat D, Shi ZH, Campos L, Rabat M, Bonnier S, Poncelet P, Laurent JC, Fiere D.
    Bone Marrow Transplant; 1990 Dec 15; 6(6):385-90. PubMed ID: 1982926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.